The reliable supply of medical radionuclides is the cornerstone of modern nuclear medicine, enabling precise diagnostic imaging and targeted radiotherapy that have transformed patient care across oncology, cardiology, and neurology. At Protheragen, we recognize that securing a stable, compliant, and efficient radionuclide supply chain is not merely a logistical challenge—it is a clinical imperative. Our integrated supply and logistics services bridge the gap between isotope production and patient administration, ensuring that your radiopharmaceutical programs remain on schedule from preclinical research through commercial launch.
Radionuclides are artificially produced radioactive isotopes that serve as the active pharmaceutical ingredients (APIs) in radiopharmaceuticals. Their production relies on highly specialized infrastructure, including research reactors, cyclotrons, and radionuclide generators, which are often geographically concentrated and distant from end-users. This geographic separation creates significant logistical constraints, particularly for isotopes with short radioactive half-lives measured in hours or days. The supply chain encompasses every stage from isotope production, quality control, and radiolabeling to packaging, cold-chain storage, and time-critical transportation.
Fig 1. Decay scheme of 227Ac. (Radchenko, Valery, et al., 2021)
Protheragen delivers comprehensive radionuclide supply and supply chain solutions designed to de-risk your radiopharmaceutical development programs. From securing scarce isotopes such as Actinium-225 and Lutetium-177 through our global supplier network, to managing the complexities of hazardous-material packaging, cold-chain logistics, and regulatory-compliant transportation, we provide an end-to-end service that ensures your clinical and commercial materials arrive on time, within specification, and ready for use. Our team combines deep expertise in nuclear medicine logistics with rigorous quality systems and real-time tracking capabilities, enabling you to focus on advancing your therapeutic pipeline while we manage the supply chain complexities that could otherwise delay patient access to life-changing radiopharmaceuticals.
We design and execute compliant packaging solutions for all classes of radioactive materials, from low-activity diagnostic tracers to high-activity therapeutic isotopes. Our services include Type A package selection and validation, integration of lead/tungsten shielding with validated cold-chain insulation, proper IATA White-I/Yellow-II/Yellow-III labeling, and complete shipping documentation. We coordinate with DOT/IATA-certified carriers to ensure safe, timely delivery by road, air, or intermodal transport, with full chain-of-custody tracking from origin to destination.
For preclinical research programs, we source and supply research-grade radionuclides and radiolabeled compounds to support biodistribution, pharmacokinetic, and efficacy studies. Our non-clinical supply service includes isotope procurement from qualified producers, custom radiolabeling coordination, small-batch dispensing, and delivery to GLP-compliant preclinical facilities. We manage all regulatory notifications and radiation safety documentation required for research use, ensuring your animal studies and in vitro assays proceed without supply interruptions.
Our clinical supply service supports Phase I–III trials and Investigator-Initiated Trials (IIT) by providing cGMP-grade radionuclides and radiopharmaceutical drug products under full quality assurance. We manage batch production scheduling aligned with patient dosing calendars, perform decay-adjusted activity calculations, and coordinate just-in-time delivery to clinical sites. Each shipment is accompanied by comprehensive batch records, certificates of analysis, and transport documentation compliant with FDA, NRC, and international clinical trial material regulations.
For approved radiopharmaceutical products, we offer commercial-scale isotope sourcing, manufacturing coordination, and nationwide distribution. Our commercial supply infrastructure includes redundant production scheduling, inventory optimization to minimize radioactive waste, and direct-to-hospital or radiopharmacy delivery networks. We maintain Master Supply Agreements (MSAs) with isotope producers and contract manufacturers, ensuring long-term supply security and scalability as your product demand grows from launch through market expansion.
Our radionuclide supply chain workflow is designed to ensure seamless integration from isotope procurement through final delivery, with rigorous quality controls and real-time monitoring at every stage. The process follows a systematic, phase-appropriate approach that adapts to the specific half-life, regulatory classification, and clinical urgency of each radionuclide.
1. Demand Forecasting & Program Planning: We begin by analyzing your clinical trial protocol, patient enrollment projections, or commercial demand forecasts to determine isotope type, activity requirements, and delivery schedules. Decay-adjusted dosing models are built to account for radioactive half-life and transit time, ensuring adequate activity at the point of administration.
2. Isotope Sourcing & Supplier Qualification: Our procurement team engages qualified isotope producers from our global supplier network, verifying cGMP compliance, reactor or cyclotron production capacity, and regulatory certifications. For scarce isotopes such as Ac-225, we leverage strategic partnerships and redundant supply agreements to mitigate shortage risks.
3. Radiolabeling & Quality Control: Upon receipt of the raw isotope, radiolabeling and formulation are performed under cGMP or GLP conditions as appropriate. Quality control testing—including radiochemical purity, specific activity, pH, sterility, and endotoxin analysis—is completed before release. Retention samples are secured for batch traceability.
4. Packaging & Labeling: Qualified personnel select and assemble Type A packaging with integrated radiation shielding and validated cold-chain components. Packages are labeled according to IATA DGR Class 7 requirements (White-I, Yellow-II, or Yellow-III), with Transport Index calculations, shipping papers, and emergency response documentation attached.
5. Transport Coordination & Real-Time Monitoring: Shipments are booked with IATA-certified carriers specializing in radioactive materials. Real-time GPS tracking, temperature logging, and radiation dose-rate monitoring are activated for the duration of transit. Dedicated logistics coordinators manage customs clearance, flight scheduling, and ground transfer to minimize transit time.
6. Receipt, Survey & Delivery Confirmation: Upon arrival, the receiving facility performs mandatory dose-rate and removable contamination surveys per 10 CFR 20.1906. Delivery confirmation, chain-of-custody documentation, and monitoring data are archived in our digital log system, accessible to clients and regulatory auditors at any time.
Whether you are initiating a preclinical radiolabeling study, scaling clinical trial material supply, or preparing for commercial launch, Protheragen is ready to architect a radionuclide supply chain solution tailored to your program's unique requirements. Reach out to our team today to discuss your isotope sourcing, packaging, and logistics needs, and discover how we can help you deliver life-changing radiopharmaceuticals to patients on time, every time. Contact us now to schedule a consultation with our nuclear medicine supply chain specialists.
Reference